Ana Ayala

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 491 citations · Full text

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

Qi Liu, Luis Fayad, Fernando Cabanillas et al. · Journal of Clinical Oncology · 2006 · 200 citations

Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · JAMA Oncology · 2021 · 108 citations · Full text

Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha

Peter McLaughlin, Elihu H. Estey, Armand B. Glassman et al. · Blood · 2005 · 90 citations · Full text

A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL

Nitin Jain, Jayastu Senapati, Beenu Thakral et al. · Blood Advances · 2022 · 72 citations · Full text